Biotech Bets, Lawsuits, and Funding
Kilder
- Endpoints: Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing
- STAT: STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
- Endpoints: Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
- BioSpace: Biopharma needs to reward scientists' judgment
- Endpoints: Spark co-founder Steven Altschuler is back with an immune-resetting biotech
- Endpoints: Exclusive: Swedish biotech AnaCardio raises $70.9M for 'safer' heart drug - Endpoints News
- Endpoints: Swedish biotech AnaCardio raises $70.9M to advance 'safer' heart failure drug
- Endpoints: Spark co-founder Steven Altschuler is back with an immune-resetting biotech - Endpoints News
- Endpoints: ARCH and Population Health return to China for new startup Somnivera, targeting sleep
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.